Milrinone
CHEBI:CHEBI_50693
Definition
A member of the class of bipyridines that is 2-pyridone which is substituted at positions 3, 5, and 6 by cyano, pyrid-4-yl, and methyl groups, respectively. It is used (particularly intravenously, as the lactate) for the short-term management of severe heart failure.
Chemical Information
- Molecular Formula
- C12H9N3O
- Molecular Mass
- 211.21948
- Charge
- 0
- SMILES
- Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N
- InChI
- InChI=1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,15,16)
- InChIKey
- PZRHRDRVRGEVNW-UHFFFAOYSA-N
Alternative Names
- 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile
- 2-methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile
- milrinona
- milrinone
- Milrinone
- milrinonum
Treatment Applications
-
critical COVID-19View Disease →
DOID:0081012
-
dilated cardiomyopathy 2DView Disease →
DOID:0081160
-
dilated cardiomyopathy 2EView Disease →
DOID:0081161
Drug Classification
-
nitrileView Class →
CHEBI:18379
-
pyridoneView Class →
CHEBI:38183
-
bipyridinesView Class →
CHEBI:50511
-
t237645
-
t238079
-
t238443
-
t238590
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:50693
- DRON_00010000
- 52769
- oboInOwl#hasDbXref
- Wikipedia:Milrinone
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- core#notation
- CHEBI:50693
- pharm_class
- Phosphodiesterase 3 Inhibitors [MoA]
- upc
- 0372485502011
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rxcui
- 1791861
- manufacturer_name
- Somerset Therapeutics, LLC
- package_marketing_start_date
- 30-JUL-07
- active_ingredient_strength
- 200 ug/mL
- spl_set_id
- bb0157d0-a414-43fa-81e0-8c92d717f1b2
- active_ingredient_name
- MILRINONE
- unii
- 9K8XR81MO8
- package_description
- 10 VIAL in 1 CARTON (0143-9326-10) / 20 mL in 1 VIAL (0143-9326-01)
- listing_expiration_date
- 20241231
- labeler_name
- Huzhou Zhanwang Pharmaceutical Co., Ltd.
- marketing_start_date
- 20070730
- route
- INTRAVENOUS
- spl_id
- 753b9d9d-f4a7-4604-8bfe-20d0a811883a
- package_ndc
- 0409-2045-10
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 52769
- oboInOwl#hasDbXref
- Wikipedia:Milrinone
- oboInOwl#hasAlternativeId
- CHEBI:6938
- oboInOwl#id
- CHEBI:50693
- generic_name
- Milrinone Lactate in 5% Dextrose
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- dosage_form
- INJECTION, SOLUTION
- brand_name
- Milrinone Lactate in Dextrose
- brand_name_base
- Milrinone Lactate in Dextrose
- product_ndc
- 0409-2045
- application_number
- ANDA211671
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_50568
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_107174
- has_treatment
- http://purl.obolibrary.org/obo/DOID_3827
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect27051
- owl#annotatedSource
- t238760
- owl#someValuesFrom
- t3001007